Search

… (WBE) has been increasingly in the spotlight since the COVID-19 pandemic began, as waste samples have been able to …

Wastewater detections show mpox likely underestimated

… dispensing in some intervention clinics prior to the COVID-19 pandemic. But the reductions weren't clinically …

Trial finds stewardship intervention neither helped nor harmed kids with respiratory tract infections

… season, a drop in drug production at the height of the COVID-19 pandemic, the outsourcing of generic ingredient and …

European consumers ask officials to do more to address antibiotics shortages

… conduct inspections in China amid its now-scrapped zero-COVID policy. Geopolitical strain is expected to rise …

Downed spy balloon may muddy US-China medical supply chains

… following the disruptions to health services caused by the COVID-19 pandemic," the researchers noted. "Even before the …

Global measles cases spiked 140% in 2019 amid falling vaccinations in many nations, study estimates

… burnout Following surveys of HCWs given during the COVID-19 pandemic, researchers were trying to assess …

Survey: Third of specialized health workers hadn't heard of mpox in 2022 before it hit their country

… while the 2,611 control patients tested negative for RSV, COVID-19, and influenza. The median age was 72 years, the …

RSV vaccine 75% effective against hospitalization in older adults, CDC study estimates

… and worsened during public health emergencies such as the COVID-19 pandemic, the authors said. Tracking outbreaks, …

GAO: Public-health workforce shortage undermines ability to respond to outbreaks, other emergencies

… flu vaccine production was sustained through the COVID-19 pandemic. The study was published this week in …

Analysis: Global season flu vaccine production stable since 2019

… catheter infections, and pneumonia since the height of the COVID-19 pandemic. Led by Columbia University School of …

Home healthcare agencies report post-pandemic infection-control progress, deficiencies

Phage Against the Routine: Resistant Acinetobacter

Defined as an “urgent” AMR threat by the US CDC, resistant Acinetobacter baumanii cause deadly infections and are difficult to remove from the environment. Acinetobacter is resistant to many antibiotics and is a frequent cause of hospital acquired infections. In the 2022 Lancet publication on drug-resistant infections (GRAM report), it was identified as the leading pathogen causing mortality in Southeast Asia. This episode will cover how infections caused by resistant Acinetobacter impact patients and on how new treatments are making an impact.

Guests:

Steffanie Strathdee - Associate Dean of Global Health Sciences, University of California San Diego School of Medicine; Author, The Perfect Predator

Greg Merril - CEO, Adaptive Phage Therapeutics

Patrick McGann - Deputy Director, Multidrug-Resistant Organism Repository and Surveillance Network (MRSN)

Jason Bennett - Director, MRSN; Associate Professor of Medicine, Walter Reed Army Institute of Research

February 28, 2023

US adds 17 more measles cases as Georgia, Iowa report new infections

With 1,214 confirmed cases, the US is inching closer to the highest number of cases reported in a single year since the disease was eliminated from the country in 2000.

… Shigella infections have been climbing since the end of COVID-19 pandemic restrictions in July 2021, and are now …

Spike in extensively drug-resistant Shigella cases reported in UK, Europe

… She said a drop in vaccination rates in the wake of the COVID pandemic gives the highly contagious measles virus the …

Chicago and Arizona report more measles cases

… they could be offered in the fall, along with the updated COVID vaccine and the annual flu shot, it's not clear how …

Arrivederci AMR: Italy and the G7 Presidency

Season 4 of Superbugs and You is here!

Episode 14: This year, Italy leads the Presidency of the G7. The group is united by common values in addressing global challenges, including antimicrobial resistance. This episode features Italian leaders driving transformational policy to battle AMR. Guests include Francesca Chiara, (CIDRAP ASP), Mariano Votta (Active Citizenship Network-Cittadinanzattiva), Damiano De Felice (CARB-X), and Massimo Sartelli (Global Alliance for Infections in Surgery).

April 2, 2024

CDC panel recommends RSV vaccine for seniors

… during the 2020-21 season, and did not return to pre–COVID-pandemic levels until 2022-23. During each flu …

From Farm to Label: Antimicrobials and One Health

One Health is a concept that recognizes this interconnection and emphasizes the need for collaborative approaches to solving the issue of antimicrobial resistance at all levels - humans, animals, and the environment is undeniable. Guests on this episode include Lance Price, (George Washington University), Francisco Diez-Gonzales (University of Georgia), and Paul Plummer (Iowa State University, NIAMRRE).

April 16, 2024

Study shows varied impact of flu in US, with up to 29,000 hospital cases in a season

Scope of the communications hold on federal health agencies expands

The pause encompasses government-related scientific meetings, travel, and the National Institutes of Health grant review process.

… which has shaped his recent policy decisions about COVID vaccines. Moderna said it will explore alternatives for …

HHS cancels funding for Moderna’s candidate H5 avian flu and pandemic vaccines

… airborne pathogens like SARS-CoV-2, the virus that causes COVID-19. A letter signed by more than 900 public health …

Trump administration shuts down federal advisory committee on infection prevention

… new findings this week about HPV vaccination during the COVID pandemic. They detailed their findings in a research …

Vaccines and the Vulnerable: The Race to End Typhoid

Over the past decade, several strains (types) of Salmonella typhi have become resistant to multiple antibiotics. Resistant strains have been identified across the globe. However, the 2018 launch of a vaccine has slowed infections. It is estimated that TCV introduction with a catch-up campaign will avert 42.5 million cases and 506,000 deaths caused by fluoroquinolone-resistant typhoid fever, and 21.2 million cases and 342,000 deaths from multidrug-resistant typhoid fever over 10 years following introduction. This episode will cover the impact of vaccinations and the challenges to deploy effective programs.

Guests:

Farah Naz Qamar - Pediatric Infectious Disease Associate Professor, The Aga Khan University, Pakistan

Kathy Neuzil - Director of the Center for Vaccine Development and Global Health, University of Maryland School of Medicine

Denise Garrett - Vice President, Applied Epidemiology, Sabin Vaccine Institute

Calman MacLennan - Senior Program Officer, Bacterial Vaccines, Bill and Melinda Gates Foundation

For more information on the impact of typhoid conjugate vaccines and AMR, check out CIDRAP-ASP's report, A Vaccine Is a Bridge: The New Era of Typhoid Prevention.

March 21, 2023

Study spotlights lower HPV vaccine uptake in higher-income groups